Search Results - "Morgan, Gareth John"

Demonstration of changes in plasma cell subsets in multiple myeloma by Ayliffe, Michael John, Davies, Faith Elizabeth, de Castro, David, Morgan, Gareth John

“…From the Department of Immunology, St. Helier Hospital, Carshalton, Surrey, UK (MJA); Section of Haemato-Oncology, The Royal Marsden NHS Foundation Trust, UK…”
Get full text

Echocardiographic guidance for neonatal right ventricular outflow tract stent implantation by Morgan, Gareth John

“…The use of combined fluoroscopic and echocardiographic imaging in congenital intervention is a well-established and developing concept. We report the case of a…”
Get more information

Feasibility of airway segmentation from three-dimensional rotational angiography by Góreczny, Sebastian, Haak, Alexander, Morgan, Gareth John, Zablah, Jenny

Get full text

Loss of heterozygosity in multiple myeloma: A role for PARP inhibition? by Pawlyn, Charlotte, Loehr, Andrea, Tytarenko, Ruslana, Deshpande, Shayu, Sun, James, Fedorchak, Kyle, Mughal, Tariq I., Davies, Faith, Walker, Brian, Raponi, Mitch, Morgan, Gareth John

“…Abstract only 8026 Background: PARP inhibitors can induce synthetic lethality in tumors characterized by homologous recombination deficiency (HRD). Two PARP…”
Get full text

Updated risk stratification model for smoldering multiple myeloma (SMM) incorporating the revised IMWG diagnostic criteria by San Miguel, Jesus, Mateos, Maria-Victoria, Gonzalez, Veronica, Dimopoulos, Meletios A., Kastritis, Efstathios, Hajek, Roman, Fernández de Larrea Rodríguez, Carlos, Morgan, Gareth John, Merlini, Giampaolo, Mangiacavalli, Silvia, Goldschmidt, Hartmut, Cavo, Michele, Kyriakou, Charalampia, Qi, Ming, Ukropec, Jon, Weiss, Brendan M., Cameron, Chris, Rajkumar, S. Vincent, Durie, Brian G., Kumar, Shaji

“…Abstract only 8000 Background: The diagnostic criteria for MM were revised in 2014, recategorizing ultra-high risk (i.e., 80% at two years) as active myeloma…”
Get full text

Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma by Costa, Luciano J., Stadtmauer, Edward Allen, Morgan, Gareth John, Monohan, Gregory P., Kovacsovics, Tibor, Burwick, Nicholas, Jakubowiak, Andrzej J., Mobasher, Mehrdad, Freise, Kevin, Ross, Jeremy A., Pesko, John Carl, Munasinghe, Wijith, Cordero, Jaclyn, Morris, Lura, Maciag, Paulo Cesar, Bueno, Orlando, Kumar, Shaji

“…Abstract only…”
Get full text

Two phase 3 studies of the oral proteasome inhibitor (PI) ixazomib for multiple myeloma (MM) in the maintenance setting: TOURMALINE-MM3, and -MM4 by Palumbo, Antonio, Morgan, Gareth John, Rajkumar, S.Vincent, Lonial, Sagar, Chng, Wee Joo, Iida, Shinsuke, Mateos, María-Victoria, Beksac, Meral, Goldschmidt, Hartmut, Labotka, Richard, Suryanarayan, Kaveri, di Bacco, Alessandra, Liao, Eileen, Wang, Bingxia, Dimopoulos, Meletios A.

“…Abstract only…”
Get full text

Lenalidomide induction and maintenance therapy for transplant eligible myeloma patients: Results of the Myeloma XI study by Jackson, Graham H., Davies, Faith, Pawlyn, Charlotte, Cairns, David A., Striha, Alina, Waterhouse, Anna, Jones, John, Kishore, Bhuvan, Garg, Mamta, Williams, Cathy, Karunanithi, Kamaraj, Lindsay, Jindriska, Jenner, Matthew, Cook, Gordon, Kaiser, Martin, Drayson, Mark, Owen, Roger G., Russell, Nigel, Gregory, Walter, Morgan, Gareth John

“…Abstract only 8009 Background: Immunomodulatory (IMiD) agents are effective therapies for multiple myeloma (MM), with Lenalidomide (Len) having fewer side…”
Get full text

Impact of total therapies on clinical outcome of myeloma stratified by risk and molecular subgroups by Heuck, Christoph Johann, Weinhold, Niels, Thanendrarajan, Sharmilan, Stein, Caleb Konrad, Van Rhee, Frits, Rosenthal, Adam, Jethava, Yogesh, Khan, Rashid, Hoering, Antje, Davies, Faith E, Barlogie, Bart, Morgan, Gareth John

“…Abstract only…”
Get full text

A new strategy to identify potentially dangerous coronary arterial patterns before percutaneous pulmonary valve implantation by Góreczny, Sebastian, Eicken, Andreas, Ewert, Peter, Morgan, Gareth John, Fratz, Sohrab

“…Despite advances in surgical techniques, right ventricular outflow tract (RVOT) conduits are prone to fail over time. Percutaneous pulmonary valve implantation…”
Get full text

Balloon-assisted closure of a large atrial septal defect - guaranteeing a soft landing by Góreczny, Sebastian, Morgan, Gareth John, Bilska, Karolina, Qureshi, Shakeel

Get full text

Methods and techniques A new strategy to identify potentially dangerous coronary arterial patterns before percutaneous pulmonary valve implantation by Góreczny, Sebastian, Eicken, Andreas, Ewert, Peter, Morgan, Gareth John, Fratz, Sohrab

“…Despite advances in surgical techniques, right ventricular outflow tract (RVOT) conduits are prone to fail over time. Percutaneous pulmonary valve implantation…”
Get full text

c-FMS chromatin structure and expression in normal and leukaemic myelopoiesis by FOLLOWS, George Alexander, TAGOH, Hiromi, RICHARDS, Stephen John, MELNIK, Svitlana, DICKINSON, Helen, DE WYNTER, Erica, LEFEVRE, Pascal, MORGAN, Gareth John, BONIFER, Constanze

“…The macrophage colony-stimulating factor receptor is encoded by the c-FMS gene, and it has been suggested that altered regulation of c-FMS expression may…”
Get full text